Lux Health Tech Acquisition Corp. Class A Common Stock
LUXA
LUXA was delisted on the 28th of October, 2022.
55 hedge funds and large institutions have $197M invested in Lux Health Tech Acquisition Corp. Class A Common Stock in 2021 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 15 increasing their positions, 8 reducing their positions, and 9 closing their positions.
134% more call options, than puts
Call options by funds: $3.35M | Put options by funds: $1.43M
100% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 9
88% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 8
20% more funds holding
Funds holding: 46 → 55 (+9)
15% more capital invested
Capital invested by funds: $171M → $197M (+$25.7M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$7.76M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
+$5.78M |
| 3 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$4.4M |
| 4 |
Millennium Management
New York
|
+$3.68M |
| 5 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
+$3.31M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$9.07M |
| 2 |
UM
Ulysses Management
New York
|
-$2.47M |
| 3 |
DC
Dendur Capital
New York
|
-$1.53M |
| 4 |
TCM
Tuttle Capital Management
Riverside,
Connecticut
|
-$330K |
| 5 |
CCM
CAAS Capital Management
New York
|
-$302K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
UBS Group
Zurich,
Switzerland
| $61K | -$8.11K | -806 | -12% |
|
|
CG
52
Cutler Group
San Francisco,
California
| $17K | -$33K | -3,284 | -64% |
|
|
TRCT
53
Tower Research Capital (TRC)
New York
| $5K | +$4.97K | +494 | New |
|
|
MF
54
Magnetar Financial
Evanston,
Illinois
| $3.13K | +$3.18M | +316,112 | New |
|
|
UM
55
Ulysses Management
New York
| – | -$2.47M | -240,209 | Closed |
|
|
DC
56
Dendur Capital
New York
| – | -$1.53M | -149,444 | Closed |
|
57
Janney Montgomery Scott
Philadelphia,
Pennsylvania
| – | -$301K | -29,324 | Closed |
|
58
HighTower Advisors
Chicago,
Illinois
| – | -$236K | -23,000 | Closed |
|
|
AGM
59
Alpine Global Management
New York
| – | -$216K | -20,996 | Closed |
|
|
PCM
60
PenderFund Capital Management
Vancouver,
British Columbia, Canada
| – | -$40K | -3,109 | Closed |
|
|
LCM
61
LH Capital Markets
New York
| – | -$10K | -1,000 | Closed |
|
62
Simplex Trading
Chicago,
Illinois
| – | -$4.88K | -485 | Closed |
|
63
Wells Fargo
San Francisco,
California
| – | -$3K | -250 | Closed |
|
64
Group One Trading
Chicago,
Illinois
| – | +$302 | +30 | New |
|
LUXA Hedge Fund Activity: Q2 2021 in Review
55 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) for Q2 2021, worth a combined $197M — up 15% from $171M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new LUXA positions and 9 closed out — a net gain of 9 holders — while 15 added to existing stakes and 8 trimmed.
The largest buyer was Weiss Asset Management, opening a new position worth an estimated $7.76M. The largest seller was Manulife (Manufacturers Life Insurance), cutting an estimated $9.07M.
- 55 institutional investors held Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) as of Q2 2021, up from 46 in Q1 2021.
- Funds reported $197M of Lux Health Tech Acquisition Corp. Class A Common Stock stock for Q2 2021, up 15% quarter-over-quarter.
- 18 funds opened new Lux Health Tech Acquisition Corp. Class A Common Stock positions in Q2 2021 and 9 closed out, a net change of +9 holders.
- The largest Lux Health Tech Acquisition Corp. Class A Common Stock buyer in Q2 2021 was Weiss Asset Management, an estimated $7.76M added.
- The largest Lux Health Tech Acquisition Corp. Class A Common Stock seller in Q2 2021 was Manulife (Manufacturers Life Insurance), an estimated $9.07M sold.
Based on aggregated 13F filings for Q2 2021.